The clinical landscape of managing patients with CKD: Where are we now and what can we expect?

Media formats available:

Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
SGLT2 inhibition in CKD: Discussing the key questions and evidence
Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
- Rajiv Agarwal, MD
Underlying mechanisms of nephroprotective effects with SGLT2i in CKD
Underlying mechanisms of nephroprotective effects with SGLT2i in CKD
SGLT2 inhibition in CKD: Discussing the key questions and evidence
Underlying mechanisms of nephroprotective effects with SGLT2i in CKD
- Paola Fioretto, MD

PACE-CME